Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:88308629:3038 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:88308629:3038?format=raw |
LEADER: 03038mam a2200397 a 4500
001 4068187
005 20221027030646.0
008 010718s2002 flua b 001 0 eng
010 $a 2001043046
016 7 $a101123104$2DNLM
020 $a084930167X (alk. paper)
035 $a(OCoLC)ocm47659396
035 $9AUQ4926HS
035 $a(NNC)4068187
035 $a4068187
040 $aNLM$cNLM$dCUY$dNNC-M$dOrLoB-B
042 $apcc
060 10 $aQZ 200$bR666m 2001
090 $aRC267$b.R634 2001
100 1 $aRoboz, John,$d1931-$0http://id.loc.gov/authorities/names/n90647901
245 10 $aMass spectrometry in cancer research /$cJohn Roboz.
260 $aBoca Raton :$bCRC Press,$c2002.
300 $axxi, 554 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $tMass Spectrometry: An Oncologist's Viewpoint --$gCh. 1.$tOverview and Scope of Applications.$g1.1.$tThe Essentials.$g1.2.$tFunctions and Types of Instrument Components.$g1.3.$tMeasures of Performance.$g1.4.$tInformation from Mass Spectra and Scope of Applications --$gCh. 2.$tInstrumentation and Techniques of Mass Spectrometry.$g2.1.$tIon Sources.$g2.2.$tMass Analyzers.$g2.3.$tIon Current Detectors.$g2.4.$tInterfaces for Sample Introduction.$g2.5.$tMass Spectrometry/Mass Spectrometry (MS/MS).$g2.6.$tIdentification and Quantification.$g2.7.$tResources --$gCh. 3.$tRelevant Concepts of Cancer Medicine and Biology.$g3.1.$tClassification and Epidemiology.$g3.2.$tCellular Proliferation and Communication.$g3.3.$tGenetic Abnormalities in Cancer.$g3.4.$tTumor Immunology.$g3.5.$tDiagnosis and Treatment.$g3.6.$tSome Pertinent Experimental Methods --$gCh. 4.$tMetabolism and Biomarkers of Carcinogens.$g4.1.$tClassification, Mechanism of Action, and Biomarkers.$g4.2.$tOccupational Carcinogens.
505 80 $g4.3.$tEnvironmental Carcinogens.$g4.4.$tDNA Damage by Radiation and Oxidation --$gCh. 5.$tMechanism of Action and Metabolism of Antineoplastic and Chemopreventive Agents.$g5.1.$tCytotoxic Therapy.$g5.2.$tEndocrine Therapy.$g5.3.$tTargeted Drug Delivery and Therapy.$g5.4.$tNutritional and Chemical Prevention --$gCh. 6.$tStrategies, Techniques, and Applications in Cancer Biochemistry and Biology.$g6.1.$tProteins and Peptides.$g6.2.$tLipids.$g6.3.$tOligonucleotides and Nucleic Acids.$g6.4.$tCarbohydrates and Glycoconjugates.
650 0 $aCancer$xResearch$xMethodology.
650 0 $aMass spectrometry.$0http://id.loc.gov/authorities/subjects/sh85081907
650 12 $aNeoplasms$xchemistry.$0https://id.nlm.nih.gov/mesh/D009369Q000737
650 22 $aAntineoplastic Agents$xmetabolism.$0https://id.nlm.nih.gov/mesh/D000970Q000378
650 22 $aBiomarkers$xchemistry.$0https://id.nlm.nih.gov/mesh/D015415Q000737
650 22 $aCarcinogens$xmetabolism.$0https://id.nlm.nih.gov/mesh/D002273Q000378
650 22 $aMass Spectrometry$xmethods.$0https://id.nlm.nih.gov/mesh/D013058Q000379
852 00 $boff,hsl$hRC267$i.R634 2002